Evidence map›Paper›PMID 40643233›Full record

ReviewmBio2025

Structural insights into

Mike Sleutel, Han Remaut

Abstract readReview
In one paragraph

Review in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Importance of Being Imperfect: Structure and Function of Bacterial Amyloid.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mike SleutelStructural Biology Brussels, Vrije Universiteit Brussel, Brussels, Belgium.ORCID 0000-0003-3247-2187
Han RemautStructural Biology Brussels, Vrije Universiteit Brussel, Brussels, Belgium.ORCID 0000-0002-9775-4102

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curli are a widespread component of proteobacterial biofilms. They are functional amyloid fibers that aid in structuring the extracellular matrix that surrounds these multicellular communities. As a functional amyloid, they are the product of a dedicated assembly pathway that needs to navigate the cytotoxicity classically associated with most amyloid depositions. Recent breakthroughs in cryo-EM and protein structure prediction have started to shed light on the unique structural principles of curli fibrils. Here, we revisit the recent literature and focus on the consensus model for these remarkable protein fibrils.IMPORTANCEAmyloid fibrils receive enormous interest as instigators of protein aggregation disorders and associated wasting diseases, as functional components of complex biological matrices, including biofilms, and/or as versatile and self-assembling protein scaffolds for protein material applications. Central to each of these phenomena are the structural properties of the component subunits and how they assemble in the amyloid fibril. A thorough understanding of these architectural principles is essential for the rational interference with amyloids, be it inhibitory in the case of disease-associated amyloids, or as a basis for biotechnological applications of functional amyloids.

Indexed as

AmyloidEscherichia coliEscherichia coli ProteinsCryoelectron MicroscopyModels, MolecularProtein ConformationProtein MultimerizationAmyloidcsgA protein, E coliEscherichia coli Proteins

Identifiers

PMID40643233
PMCPMC12345197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.